Accelerate Your Biomarker Discovery & Validation with a Partner Who Speaks Your Scientific Language.
|
|
Tebubio combines the multiplex technologies of RayBiotech, FullMoon BioSystems, and Quansys Biosciences with in-house Biomarker Profiling and Biostatistics services, supporting scientists from raw samples to publication-ready data. Our integrated workflow facilitates biomarker discovery, pathway mapping, and quantitative validation, giving you consistent, reliable results. And that’s just the beginning. Tebubio offers a broad range of tools and services to standardise and accelerate biomarker studies across multiple biological models. |
Discover → Decode → Quantify
We integrate complementary technologies into a single continuum, guiding scientists from large-scale biomarker discovery, through mechanistic pathway decoding, to quantitative validation (Figure1).
-
Discovery with RayBiotech Arrays: Screen hundreds to thousands of proteins in a single assay to uncover novel or modulated biomarkers linked to disease, treatment, or cellular response.
-
Mechanistic Insight with FullMoon Phospho-Arrays: Map phosphorylation events and pathway activity to understand the biological mechanisms behind your findings.
-
Quantitative Validation with Quansys & RayBiotech ELISAs: Validate selected biomarkers with precision using Quansys Q-Plex™ multiplex ELISAs or RayBiotech Quantibody® arrays. Single-analyte ELISA kits allow one-target quantification.
This integrated continuum ensures consistent, publication-ready data from discovery to mechanism to quantification.
Our Stepwise Approach
| Step | Objective | Technology | Typical Output |
|---|---|---|---|
| 1. Broad Discovery | Identify hundreds to thousands of candidate biomarkers across cytokines, receptors, and growth factors |
RayBiotech multiplex arrays: – ultra-broad panels (up to ~8,000 proteins using high-density antibody spotting) |
Semi-quantitative expression data and biomarker signatures |
| 2. Pathway & Mechanistic Insight | Explore signalling networks and post-translational modifications | FullMoon BioSystems antibody arrays – up to ~1,358 antibodies on a single slide covering >20 signalling pathways | Site-specific phosphorylation profiles and pathway activation maps |
| 3. Targeted Quantification | Quantitatively validate selected biomarkers and compare conditions with precision | Quansys Q-Plex™ multiplex ELISAs – multiple analytes per well with chemiluminescent detection RayBiotech Quantibody® multiplex ELISAs >30.000 single-analyte quantification ELISA kit references |
Fully quantitative concentration data for each analyte |
Together, these platforms deliver a 360° view of biomarker biology, enabling you to:
-
Discover novel targets
-
Decode molecular mechanisms
-
Validate findings with quantitative confidence
The Technologies Behind Our Success
We partner with leading innovators to provide complementary technologies for every stage of biomarker research.
| Technology | Technical Highlights | Best Suited For |
| RayBiotech Multiplex Assays | Up to 8,000 human proteins; 700+ multiplex arrays; compatible with serum, plasma, cell lysates; 20 µL sample | Broad discovery, multiplex profiling, biomarker screening, cytokine mapping, disease signature exploration |
| FullMoon Products | Site-specific phosphorylation profiling (>1,000 targets); pathway-specific panels; analysis of post-translational modifications | Pathway mapping, mechanistic studies, drug response, signalling cascade analysis |
| Quansys Multiplex Assays | Multiplex ELISA for 16 analytes per well; sensitive chemiluminescent detection; low sample volume; automated Q-View™ analysis | Targeted quantitative validation, clinical biomarker panels, dose-response studies, and reproducibility assessment |
Your Choice: Do It Yourself
You can either use RayBiotech, FullMoon, or Quansys kits in your own lab.
It Sounds Complex? That’s Exactly Why We’re Here
Multiplex arrays, phospho-profiling, and quantitative ELISAs can seem technical, even daunting. You don’t need to master the technology; we do it for you.
- Entrust our European CRO Biomarker Profiling experts to perform the complete analysis in Europe.
- Save time: sample-to-data
- Publication-ready figures: heatmaps, pathway analysis & statistical outputs
Case Study: From Complex Data to Clear Insights
As part of our biomarker research services, Tebubio’s CRO laboratory profiled over 200 cytokines in OXA-treated fibrosarcoma models using multiplex antibody arrays. This comprehensive analysis revealed 47 biomarkers linked to immune activation and tumour regression, providing new insight into the molecular drivers of therapeutic response.
Have a look at the Multiplex Antibody Array for Comprehensive Protein Profiling and Biostatistical Analysis – Tebubio.
Figure 2: Data profiling of the biomarker expression in OXA-treated and untreated MCA205 cells.
Left - Principal Component Analysis (PCA) comparing two groups of samples, OXA-treated (pink) and untreated cells (green).
Right - Heatmap displaying biomarker expression profiles of OXA-treated (pink) and untreated cells (green).
The study, Standardised 3D Spheroid Systems for Advanced Drug Screening and Biomarker Discovery – Tebubio, demonstrates how our integrated workflow brings everything together: discovery arrays, phospho-analysis, multiplex ELISAs, 3D spheroid systems, and advanced biostatistics.
The outcome: complex proteomic data transformed into clear, publication-ready biological insights.
This is just one example of what Tebubio’s CRO team achieves every day, combining scientific precision, proven technologies, and tailored expertise to help you uncover what matters most in your research.
Let’s discuss how we can adapt our workflow to your study objectives. Send us your samples, and we'll send you the results!
Your Biomarkers, Your Way
|
At Tebubio, flexibility meets expertise. Discuss your project with our experts, with over 15 years of biomarker experience. Choose how you work: → Run it yourself with RayBiotech, FullMoon, or Quansys kits, backed by our expert support.
"Your biomarkers, your way, whether you run the assay yourself or let us do it for you." |
 |
Ready to discuss your project?
Complete the form below or contact our Biomarkers experts to start the conversation.